Previous 10 | Next 10 |
Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023 PR Newswire PLEASANTON, Calif. , Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and f...
Summary Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality. Fast facts on GNOM. 10 stocks cheaper than their peers in January. This monthly article...
Summary Bruker offers a range of advantages over peers: profitability, value, growth, and more. As such, the company is well-positioned to provide strong returns in the future. This article will address recent developments, highlight the advantages, and discuss the opportunity. ...
(All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) provides 2023 operational guidance as well as a 5-year production outlook for the Morelos Comp...
TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports record annual gold production of 474,035 ounces in 2022 following fourth quarter production of 116,196 ounces. Full year gold production surpassed the upp...
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire PLEASANTON, Calif. , Dec. 28, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today annou...
Summary 10x Genomics is targeting larger addressable market opportunities over the mid to long term. The accelerated Xenium launch will bolster the growth potential but may be insufficient to plug a looming shortfall next year. While cost cuts will help, it remains unclear if they w...
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis PR Newswire Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif. , Dec. 8, 2022 /PRNewswire/ -- 10x Ge...
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery PR Newswire Barcode Enabled Antigen Mapping (BEAM) screens multiple antigens against thousands of B- or T-cells to identify novel and rare antigen-specific repertoires ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...